Publications by authors named "Moreno Festuccia"

26Publications

Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients.

Ann Hematol 2018 Nov 9;97(11):2205-2215. Epub 2018 Jul 9.

Department of Oncology, SSD Trapianto Allogenico, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Via Genova 3, 10126, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3433-3DOI Listing
November 2018

Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2018 08 21;24(8):1765-1770. Epub 2018 Apr 21.

A.O.U. Città della Salute e della Scienza, Dipartimento di Oncologia, SSD Trapianto allogenico di cellule staminali, Turin, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183022
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.04.022DOI Listing
August 2018

Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.

Front Immunol 2017 7;8:1444. Epub 2017 Nov 7.

Department of Oncology/Hematology, A.O.U. Città della Salute e della Scienza di Torino, Presidio Molinette, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2017.01444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682004PMC
November 2017

Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma.

Biol Blood Marrow Transplant 2018 01 4;24(1):189-193. Epub 2017 Oct 4.

Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy; Department of Oncology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791173075
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2017.09.017DOI Listing
January 2018

Immuno-oncologic Approaches: CAR-T Cells and Checkpoint Inhibitors.

Clin Lymphoma Myeloma Leuk 2017 08 17;17(8):471-478. Epub 2017 Jun 17.

Department of Molecular Biotechnology and Health Sciences, University of Turin, Struttura Semplice Dipartimentale Allogeneic Stem Cell Transplant, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.06.014DOI Listing
August 2017

Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents.

Biol Blood Marrow Transplant 2017 Sep 30;23(9):1509-1514. Epub 2017 Jun 30.

Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Medical Oncology, University of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, WA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481669PMC
September 2017

Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2017 Mar 27;23(3):388-397. Epub 2016 Dec 27.

Department of Oncology, AOU Città della Salute e della Scienza di Torino, Presidio Molinette, Torino, Italy; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.12.632DOI Listing
March 2017

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report.

J Hematol Oncol 2016 08 8;9(1):67. Epub 2016 Aug 8.

Department of Oncology, SSCVD Trapianto di Cellule Staminali, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-016-0298-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977623PMC
August 2016

Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome.

Biol Blood Marrow Transplant 2016 07 6;22(7):1227-1233. Epub 2016 Apr 6.

Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.03.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999078PMC
July 2016

Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation.

Expert Rev Hematol 2016 Jun 18;9(6):585-96. Epub 2016 Apr 18.

a Department of Oncology, SSCVD Trapianto di Cellule Staminali , A.O.U. Città della Salute e della Scienza di Torino , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2016.1174571DOI Listing
June 2016

Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents.

Expert Opin Biol Ther 2016 6;16(3):347-64. Epub 2016 Feb 6.

b Division of Hematology, A.O.U. Citta' della Salute e della Scienza di Torino - Presidio Molinette, and Department of Molecular Biotechnology and Health Sciences , University of Torino , Torino , Italy.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14712598.2015.11
Publisher Site
http://dx.doi.org/10.1517/14712598.2015.1130821DOI Listing
October 2016

Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs.

Expert Opin Biol Ther 2015 Jun 12;15(6):857-72. Epub 2015 Apr 12.

University of Torino, Presidio Molinette, and Department of Molecular Biotechnology and Health Sciences, Division of Hematology, A.O.U. Citta' della salute e della scienza di Torino, Presidio Molinette , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2015.1036735DOI Listing
June 2015

Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents.

Ann Hematol 2014 Aug 6;93(8):1391-400. Epub 2014 Apr 6.

Section of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Turin, via Genova, 3, 10126, Turin, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2047-7DOI Listing
August 2014

Recurrent plasmacytomas after allografting in a patient with multiple myeloma.

Case Rep Med 2012 25;2012:168785. Epub 2012 Dec 25.

Department of Hematology and Oncology, Webber Cancer Center, St. John Macomb-Oakland Hospital, Warren, MI 48093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/168785DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541793PMC
January 2013

Role of allogeneic transplantation in multiple myeloma in the era of new drugs.

Mediterr J Hematol Infect Dis 2010 Jun 1;2(2):e2010013. Epub 2010 Jun 1.

Division of Hematology at the S. Giovanni Battista Hospital, University of Torino, Via Genova 3, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2010.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033139PMC
June 2010